IV Infusion Set and Hospital Consumables Supplier for Gulf Hospital Procurement

What we do is source finished, sterile devices from ISO 13485-certified manufacturers and put them, with the manufacturer's compliance documentation, into your purchase order or your local agent's tender. What we do not do is hold your country's medical-device registration ourselves, because a foreign trading house cannot. That registration sits with your appointed in-Kingdom or in-UAE authorised representative, and we will not pretend otherwise. If you want a fast quote against a NUPCO line, an SFDA-registered item, or a specific hospital catalogue code, message us on WhatsApp with the item description, drop factor, pack size and quantity, and we will come back with source options and the documentation each carries.

The infusion and consumables range we source.

The core lines we quote most often are single-use gravity-feed IV administration sets, burette (measured-volume) sets, blood and blood-component transfusion sets, extension lines, and stopcocks and fluid-line accessories. These are the disposables a hospital orders by the case, so the questions that matter to you are the source standard, the sterility method, and the documentation that ships with each lot.

Gravity-feed IV administration sets are governed internationally by ISO 8536-4, current edition ISO 8536-4:2019 (the sixth edition, which superseded the 2010 edition). That standard sets the material, physical, chemical, biological, labelling and packaging requirements and standardises how set components are designated, so that a set is compatible with infusion-solution containers and IV equipment. The CEN-adopted version is BS EN ISO 8536-4:2020, which supersedes the withdrawn 2010 edition, and a revision of the 2019 edition is in progress. A typical set includes a closure-piercing spike (often air-vented), a drip chamber, tubing, a flow regulator or roller clamp, an injection site such as a Y-port, and a male luer connector with a protective cap, though components vary by product and set type. Drop factor also varies: macrodrip sets are typically around 20 drops per ml of a specified test solution under defined conditions, while microdrip or paediatric sets are typically 60 drops per ml. A set may include a fluid filter, but pore size is not fixed by ISO 8536-4 and varies by product, so we confirm it per item rather than quoting a universal figure.

Burette or measured-volume sets fall under ISO 8536-5, which covers single-use gravity-feed burette infusion sets in 50 ml, 100 ml and 150 ml nominal capacities. Blood and transfusion sets are covered by ISO 1135-4, current edition ISO 1135-4:2025 (the seventh edition, superseding the 2015 edition), for single-use gravity-feed transfusion sets compatible with blood-component containers and IV equipment. Stopcocks and fluid-line accessories fall under ISO 8536-10, which covers sterile single-use accessories including two-way, three-way, four-way and manifold stopcocks and units with an injection site or check valve. Luer connectors on these lines are addressed by ISO 80369-7:2016, adopted in Europe as EN ISO 80369-7:2021, which specifies small-bore connectors for intravascular and hypodermic use and replaced the older ISO 594-1 and ISO 594-2 Luer standards; the newer connectors are designed to remain dimensionally compatible with legacy Luer-slip and Luer-lock fittings, subject to functional testing.

The quality standards a Gulf buyer should ask us to prove.

The certification you expect the actual manufacturer to hold is ISO 13485:2016, the internationally recognised medical-device quality management system standard (third edition, published 1 March 2016, reviewed and confirmed as current in 2025). Because we are the trader and not the maker, we do not hold ISO 13485 as a device manufacturer, and there is no ISO standard that certifies a merchant-exporter as one. What we do is confirm that the source manufacturer holds a valid ISO 13485 certificate, and we supply that certificate with the goods.

Biocompatibility for anything in the patient or fluid path is evaluated under the ISO 10993 series. ISO 10993-1 provides the risk-management framework that determines which tests apply by the nature and duration of body contact; the newest edition is ISO 10993-1:2025, which supersedes ISO 10993-1:2018, though the 2018 edition remains the version recognised by the US FDA for its submissions. Sterility for these disposables is validated to a Sterility Assurance Level of 10 to the minus 6, meaning a one-in-a-million probability of a non-sterile unit. Plastic infusion sets that cannot be steam-sterilised are commonly sterilised by ethylene oxide, validated under ISO 11135:2014 (with Amendment 1:2018) through the IQ, OQ and PQ validation phases; radiation sterilisation is validated under the ISO 11137 series. Residual ethylene oxide and ethylene chlorohydrin limits are set by ISO 10993-7, which specifies allowable residues by exposure category.

For devices that carry a CE mark, conformity is against Regulation (EU) 2017/745, the Medical Device Regulation, which became fully applicable on 26 May 2021 and replaced the earlier Medical Device Directive. On the plasticiser question that Gulf tenders increasingly raise: DEHP, historically the most common plasticiser in PVC medical devices, is a REACH Substance of Very High Concern classified CMR Category 1B. Under EU MDR Annex I Section 10.4, devices containing DEHP above 0.1 percent by weight must be labelled as such and carry a benefit-risk justification. The European Commission has extended the REACH authorisation sunset for DEHP in medical devices to 1 July 2030. Where you require DEHP-free product, we can source sets using alternative plasticisers such as DOTP (DEHT), TOTM, ATBC or DINCH, which are increasingly used in medical-grade PVC tubing; we confirm the DEHP-free status per manufacturer rather than assuming it.

How Gulf medical-device procurement actually works, and where we sit.

The most important thing to understand, and the point where honest suppliers separate from overpromising ones, is that medical devices register and procure through a different route than drugs. A medical device achieves its effect by physical or mechanical means, not by pharmacological, immunological or metabolic action, so it goes down the device pathway of risk classification plus technical file and QMS evidence, not the pharmaceutical-registration pathway. It is the same split we describe on the pharmaceutical side in our Saudi SFDA and NUPCO buyer guide, applied to devices.

In Saudi Arabia, a device needs a Medical Device Marketing Authorization (MDMA) from the SFDA before it can be imported, distributed or sold. Devices are risk-classified as Class A, B, C or D, and a single-use gravity-feed infusion set is a lower-risk device, though the exact class letter is an SFDA determination that depends on the specific product, so it should be verified per device. A foreign India-based party cannot register directly with the SFDA. The application must be submitted through the SFDA's GHAD portal by a Saudi-resident Authorised Representative holding a valid AR licence and a Medical Device Establishment Licence, and the AR or importer is the SFDA-facing licence holder. The MDMA can be valid for up to 3 years and must be renewed before expiry; the establishment licences are issued for one year with annual renewal. For public hospitals, procurement runs through NUPCO, the National Unified Procurement Company, established in 2009 and owned by the Public Investment Fund, which aggregates demand and runs consolidated framework tenders against a Unified Catalogue. A valid SFDA registration is a prerequisite for offering a device into a NUPCO tender, and catalogue inclusion is effectively required to supply public hospitals through NUPCO. Saudi procurement also increasingly applies local-content preferences under the LCGPA and the Made in Saudi programme, which is a commercial and policy consideration rather than a device-registration requirement.

In the UAE, device registration is a federal process that moved from MOHAP to the Emirates Drug Establishment (EDE) under Federal Decree-Law No. 38 of 2024, effective 2 January 2025. A foreign manufacturer must appoint a UAE-based Local Authorised Representative that is establishment-registered with the regulator; the LAR submits the registration, holds the marketing authorisation and handles post-market obligations, and a foreign merchant-exporter cannot self-register. UAE registrations are generally valid for 5 years, and the dossier typically requires a QMS certificate such as ISO 13485, a Certificate of Free Sale, technical documentation, evidence of prior approvals such as CE marking or FDA clearance, and Arabic labelling. Emirate-level bodies such as the Dubai Health Authority and the Department of Health in Abu Dhabi license facilities and professionals but do not separately register devices. Industry reporting also indicates that from early 2026 the EDE moved away from a single-exclusive-distributor model, allowing more than one appointed agent per product, though the exact scope should be verified before you rely on it commercially.

Where M Care fits, honestly stated.

Our role is straightforward and bounded. We source IV infusion sets, burette sets, transfusion sets, extension lines and stopcocks from ISO 13485-certified manufacturers, and we supply the product together with the manufacturer's compliance pack into your purchase order or into your local agent's tender. That pack typically includes the manufacturer's ISO 13485 certificate, the CE certificate or Declaration of Conformity, ISO 8536-4 and ISO 10993 test evidence, sterilisation validation records under ISO 11135 or ISO 11137 and lot sterility records, a Certificate of Analysis, and free-sale or origin documents. We confirm these documents exist and are current before we quote, because your buyer-market registration relies on the manufacturer's evidence, not on ours.

What we do not do, and will not claim, is hold the SFDA or EDE marketing authorisation or the local establishment licence. Those sit with your appointed in-market authorised representative, importer or distributor. The legal-manufacturer role sits with the entity named on the device and its technical file, not with a trading intermediary, and we do not become the registrant by handling the goods. If you already have an AR or distributor appointed, we supply into their tender. If you are earlier in the process, we can point you to what the manufacturer's documentation will and will not support, so your AR knows what they are working with before they file.

For a quote, WhatsApp is the fastest route. Send us the item description or catalogue code, the drop factor and pack configuration, whether you need DEHP-free, the destination market and the quantity, and we will respond with source options and the documentation each one carries. If a line is meant for a NUPCO or EDE tender, tell us the reference so we can check that the source documentation matches what the tender asks for before you commit.

FAQ

Are you the manufacturer of these IV infusion sets?

No. We are an India-based merchant-exporter, a sourcing and trading house. We source finished sterile sets from ISO 13485-certified manufacturers and supply them with the manufacturer's compliance documentation. We do not manufacture the devices and we do not hold manufacturer certifications ourselves.

Can M Care register these devices with the SFDA or the UAE EDE for us?

No. A foreign trading house cannot hold the Gulf device registration. In Saudi Arabia the SFDA Medical Device Marketing Authorization is submitted through the GHAD portal by a Saudi-resident Authorised Representative holding the establishment and AR licences. In the UAE the registration is held by a UAE-based Local Authorised Representative registered with the Emirates Drug Establishment. We supply the product and the manufacturer's documentation into that registered agent's or importer's process; we do not become the registrant.

Why do infusion sets follow a different route than the medicines you also export?

Because a medical device achieves its effect by physical or mechanical means rather than by pharmacological, immunological or metabolic action, so it goes down the device pathway of risk classification plus technical file and QMS evidence. In both Saudi Arabia and the UAE that is a separate registration route from pharmaceutical registration, run under the SFDA and EDE device frameworks respectively.

What standards do the sets you source meet?

Gravity-feed IV administration sets are made to ISO 8536-4 (current edition ISO 8536-4:2019). Burette sets follow ISO 8536-5, transfusion sets follow ISO 1135-4 (current edition ISO 1135-4:2025), and stopcocks follow ISO 8536-10. The manufacturer is expected to hold ISO 13485:2016, with biocompatibility under the ISO 10993 series and sterilisation validated under ISO 11135 (ethylene oxide) or the ISO 11137 series (radiation) to a Sterility Assurance Level of 10 to the minus 6. We confirm which apply per item and supply the evidence.

Can you supply DEHP-free infusion sets?

Yes, where you require it and the source manufacturer offers it. DEHP is a REACH Substance of Very High Concern, and the EU has extended its authorisation sunset in medical devices to 1 July 2030, with labelling and justification required above 0.1 percent by weight under EU MDR Annex I 10.4. DEHP-free sets commonly use alternative plasticisers such as DOTP, TOTM, ATBC or DINCH. We confirm the DEHP-free status per manufacturer rather than assuming it.

Do these sets need SFDA registration before a NUPCO tender in Saudi Arabia?

Yes. A valid SFDA registration is a prerequisite for offering a device into a NUPCO tender, and Unified Catalogue inclusion is effectively required to supply public hospitals through NUPCO. That registration is held by your Saudi Authorised Representative or importer. We supply the product and documentation to support their bid; we do not hold the registration or the NUPCO prequalification ourselves.

What is the fastest way to get a quote?

WhatsApp us with the item description or catalogue code, drop factor and pack size, whether you need DEHP-free, the destination market (Saudi Arabia or UAE) and the quantity. We respond with source options and the documentation each one carries. If it is for a NUPCO or EDE tender, share the reference so we can check the source documentation against what the tender asks for.